Year: 2022
Type: article
Abstract: In 2019, the World Health Organization (WHO) reported that approximately 280 million individuals were living with depression, including 23 million children and adolescents. Research indicates that individuals with depression experience impaired physical, social, and work functioning, directly impacting their quality of life. As a result, the need for accessibility to a wide range of antidepressant medications is crucial. This review aims to provide an overview of conventional antidepressant medications, evaluate the efficacy, safety, and tolerability of newly emerged drugs for unipolar depression treatment, and highlight promising medications in different stages of development, with the goal of expanding the therapeutic options available for depression.
Author: Andreea Sopu
Institution: Spitalul Clinic de Psihiatrie Alexandru Obregia
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4408201753